NDC 16729-366-46 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-366
- Requested NDC
- 16729-366-46
- Package NDCs from labels
- 16729-366-10, 16729-366-15, 16729-366-16, 16729-366-17, 16729-366-45, 16729-366-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-366-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-366-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-366-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-366-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-366-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-366-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-366-10 | EA - Each | 16729-366 | 39fc2de8-f862-4a2d-a12c-bfab23d6c60e | 1 | 2020-09-14 |
| 16729-366-15 | EA - Each | 16729-366 | 3400d9ab-caf6-4425-9c27-24a6d36b5abb | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF30 | TITANIUM DIOXIDE AND ZINC OXIDE | DERM ASSO. MID OHIO | 2d04bc5d-6f11-4f56-e063-6294a90ae755 | 2025-01-31 | Warnings | 15FIX9V2JP |
| TiZO Mineral Sun Defense SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals Ltd. | 2d0766a1-4091-e84a-e063-6394a90a004a | 2025-01-31 | Warnings | 15FIX9V2JP |
| COVER plus CORRECT/TINTED MOISTURIZER CC CRM FAIR | OCTINOXATE, OCTISALATE, OXYBENZONE, AND TITANIUM DIOXIDE | Bluemercury | 5c590aed-d2f2-4478-8919-37c848752b42 | 2025-01-29 | Warnings | 15FIX9V2JP |
| LiProtect SPF 35 | ZINC OXIDE, TITANIUM DIOXIDE | Science of Skincare | 0d0a2657-4098-3c60-e063-6294a90acabb | 2025-01-29 | Warnings | 15FIX9V2JP |
| Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE AND ZINC OXIDE | BELLE MEDICAL LLC | 2cdc69d3-2192-7a38-e063-6294a90a257f | 2025-01-29 | Warnings | 15FIX9V2JP |
| Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE AND ZINC OXIDE | Boxbar Beauty LLC | 2d04c5e7-f3aa-873f-e063-6294a90a33d2 | 2025-01-29 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_rx | 1ba299e7-0651-c23b-e063-6294a90a0245 | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| TiZO Mineral Sun Defense SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals Ltd. | 2cc8f7ef-eda3-fe71-e063-6394a90a6a9a | 2025-01-28 | Warnings | 15FIX9V2JP |
| Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE AND ZINC OXIDE | Z&Z Skin Essentials | 2cdc48f3-474f-9c06-e063-6294a90afea1 | 2025-01-27 | Warnings | 15FIX9V2JP |
| Cetaphil Sheer Mineral Sunscreen Stick SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | Galderma Laboratories, L.P. | 54f6df65-e90c-4070-aa95-f47496dd11bd | 2025-01-27 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8b36fa56-4274-4fc6-bdba-ca7a399b2b21 | 2025-01-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| CoTZ Silky Foam - Tinted | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | d63088d7-a1d7-4b56-a7d8-ad217011a8a8 | 2025-01-24 | Warnings | 15FIX9V2JP |
| CoTZ Silky Foam Non-Tinted | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | 9c04b76e-ae65-4183-b475-3b8e8764db59 | 2025-01-24 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Redpharm drug | fa1c0b92-4360-bcfd-e053-6394a90a955a | 2025-01-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b4f5dd93-5f44-4c8c-9e3b-89ab1fa5a7fd | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | e64c3b3b-d5e7-6d46-e053-2a95a90a1b64 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Direct_Rx | 05156717-fe1b-22f1-e063-6394a90a3d10 | 2025-01-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Prunus Iron | PRUNUS IRON | Uriel Pharmacy Inc. | 091be588-b62e-4919-8e9e-3edb9792d319 | 2025-01-22 | Warnings | 1K09F3G675 |
| METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Ajanta Pharma USA Inc. | 8b78d7ad-22a8-4a9f-afb5-d18f0a4e6d36 | 2025-01-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d8284747-07b6-9775-e053-2a95a90ad52d | 2025-01-21 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.